| Financial Year |
March 31 2023 |
| Monetary Funds |
2,964,912,277.41 |
| Held-for-trading Financial Assets |
228,763,829.39 |
| Notes Receivable |
8,890,000.00 |
| Accounts Receivable |
171,214,182.43 |
| Advances to Suppliers |
135,744,546.66 |
| Other Receivables |
7,720,604.68 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,393,887,470.07 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
21,518,326.75 |
| Other Current Assets |
26,688,888.11 |
| Total Current Assets |
6,069,406,073.03 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
21,827,982.57 |
| Investment Properties |
-- |
| Fixed Assetes |
584,202,857.81 |
| Under-construction Projects |
310,198,692.79 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
782,220,543.45 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
295,653,380.20 |
| R&D expenses |
-- |
| Goodwill |
131,955,305.39 |
| Long-Term Deferred and Prepaid Expenses |
45,391,278.91 |
| Deferred Income Tax Assets |
29,501,353.31 |
| Other Non-Current Assets |
1,553,673,399.85 |
| Sub-Total of Non-Current Assets |
4,478,677,682.25 |
| Total Assets |
10,548,083,755.28 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
63,928,809.79 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
71,319,447.68 |
| Taxes Payable |
20,531,639.36 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
200,017,252.79 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
29,959,701.03 |
| Other Current Liabilities |
6,274,465.84 |
| Sub-Total of Current Liabilities |
1,854,544,562.53 |
| Long-term Loans |
2,345,200.71 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
192,645,233.21 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
331,392,775.99 |
| Total Liabilities |
2,185,937,338.52 |
| Paid-In Capital(Or Share Stock) |
535,678,676.00 |
| Capital Surplus |
5,479,342,217.05 |
| Surplus Reserve |
119,510,687.07 |
| LESS:Treasury Stock |
64,386,543.74 |
| Undistributed Profits |
2,193,731,531.76 |
| Minority Stockholder's Interest |
7,115,118.65 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,355,031,298.11 |
| Owner's Equity（Stockholder's Equity） |
8,362,146,416.76 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,548,083,755.28 |
